ABOS (acumenpharm.com) Sof foyda

ABOS (acumenpharm.com) - kompaniyaning tovar belgisi

Acumen Pharmaceuticals (ABOS) kompaniyasining tajribali rahbariyati Altsgeymer kasalligi uchun terapiya usullarini kashf etishga e'tibor qaratgan. Biroq, II bosqich sinovlarining xarajatlari va FDA ning qat'iy talablari sezilarli moliyaviy bosimni keltirib chiqarmoqda. Geopolitika ham patent himoyasi va komponentlar logistikasini murakkablashtirmoqda. Kompaniyaning sof balansi bozor konsensusini aks ettiradi, bunda -0.10 qiymati joriy foyda miqdorini ko'rsatadi.

Acumen Pharma (ABOS): Sof daromad 04.07.2022dan 29.10.2026gacha

Acumen Pharmaceuticals, Inc. (ABOS) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Acumen Pharmaceuticals, Inc|ABOS - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Acumen Pharmaceuticals, Inc|ABOS - Korxona qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun buxgalteriya qiymati Acumen Pharmaceuticals|ABOS - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati acumenpharm.com|ABOS - Kompaniyaning jami aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning xususiy kapitalga nisbati Acumen Pharmaceuticals|ABOS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Acumen Pharmaceuticals Inc.|ABOS - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Acumen Pharmaceuticals, Inc|ABOS - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Acumen Pharmaceuticals|Kritik likvidlik koeffitsiyenti acumenpharm.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
ABOS - Sof foyda
Kompaniyaning asosiy tahlili:Acumen Pharmaceuticals, Inc
Acumen Pharmaceuticals asosiy tovari

Acumen Pharmaceuticals (ABOS) sog'liqni saqlash giganti tajribali mutaxassislari tomonidan tadqiqot va ishlanmalar (R&D) xarajatlarining samarali nazorati bevosita foyda dinamikasini belgilaydi va barcha operatsion xarajatlardan keyin qoldiq kapitalni yaratishning biznes imkoniyatlarini o'lchaydi. Bozor o'sishi fonida kompaniyaning sof foydasi kamayishi uning fundamental xavfsizlik zaxirasining qisqarganidan dalolat beradi, bu esa investorlarni joriy moliyaviy barqarorlik va kelajakdagi potentsial daromadlar o'rtasida muvozanat izlashga majbur qiladi.

Muhim raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Sof foyda|Sof foyda regencellbioscience.com|Sof foyda AXSM|Sof daromad ACADIA Pharma ACAD|Xenon Pharmaceuticals Inc - Sof daromad|Sof foyda Viking Therapeutics Corp VKTX|SUPN - Kompaniyaning sof foydasi|catalystpharma.com (CPRX) - Sof daromad|DNLI: Sof foyda|Kompaniyaning sof daromadi Harmony Biosciences Inc (HRMY)|Kompaniyaning sof foydasi Biohaven Pharmaceutical|Kompaniya foydasi AMLX (Amylyx Corp)|Sof daromad TRVI (Trevi Therapeutics)|PRAX (praxismedicines.com) - Yakuniy foyda|Kompaniyaning sof foydasi Anavex Life Sciences Corp. AVXL|CBLL (CeriBell Inc) - Soliqdan keyingi foyda|Prothena Biosciences - Sof foyda|Yakuniy foyda ALEC (Alector, Inc.)|ANNX: Sof foyda|Omeros (OMER) - Sof foyda|Kompaniyaning sof foydasi Neurogene|ACIU: Yakuniy foyda|Kompaniyaning sof foydasi Voyager Pharma (VYGR)|Sof daromad Neumora Corp NMRA|Sof foyda SCLX (Scilex Holding Company)|Sof foyda tevogen.com TVGN|Alpha Cognition Corp - Sof foyda|cogrx.com (CGTX) - Sof daromad|IKT: Sof foyda|Kompaniyaning sof daromadi Cassava Pharma (SAVA)|Sof daromad ASRT|Sof foyda Coya|Sof daromad VTGN (Vistagen Therapeutics)|Soliqlar to‘langandan keyingi foyda OVID|Sof foyda CRVO (CervoMed Inc)|Sof moliyaviy natija Alterity Therapeutics Ltd. (ATHE)|Clene Nanomedicine - Sof foyda|PepGen Inc. (PEPG) - Sof daromad|JUNS: Sof foyda|Relmada Therapeutics Inc (RLMD) - Sof foyda|Kompaniyaning sof foydasi Annovis Bio Corp|Kompaniyaning sof foydasi GRCE|Kompaniyaning sof foydasi Firefly Neuroscience, Inc (AIFF)|Sof moliyaviy natija anewmeds.com|Sof foyda NRSN (NeuroSense Therapeutics Ltd.)|Sof foyda Reviva Pharmaceuticals Holdings Inc. RVPH|MetaVia, Inc. - Sof foyda|NRXS: Kompaniyaning sof foydasi|heliusmedical.com (HSDT) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Passage Bio (PASG)|Kompaniyaning sof foydasi Neuphoria Therapeutics, Inc.|Minerva Neurosciences Inc (NERV) - Sof moliyaviy natija|Kompaniyaning sof foydasi Athira (ATHA)|Addex - Kompaniya foydasi|Sof foyda ALZN (Alzamend Neuro)|Cyclerion Therapeutics Inc. (CYCN) - Kompaniyaning sof daromadi|PTIX: Sof daromad|KTTA - Sof foyda|cortigent.com (CRGT) - Kompaniyaning sof foydasi|Avenue Therapeutics Inc - Yakuniy foyda|Kompaniyaning sof foydasi Brainstorm Cell|Kompaniyaning sof daromadi caratherapeutics.com CARA|Sof foyda CHRO|Sof foyda eliemtx.com (ELYM)|Sof foyda ITCI (Intra-Cellular Therapies, Inc.)|LBPH - Sof daromad|MRNS: Sof daromad|NKGN - Sof foyda|NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning sof foydasi|Sof daromad Sage Therapeutics Inc.|SNPX (Neurotrope) - Sof foyda|Kompaniyaning sof daromadi Trevena Inc TRVN|Kompaniyaning sof foydasi Vigil Neuroscience (VIGL)|Anew Medical Inc. - Kompaniya foydasi|Cerevel Therapeutics, Inc. - Sof daromad